Concepedia

Publication | Open Access

Rituximab add-on therapy for breakthrough relapsing multiple sclerosis

215

Citations

26

References

2010

Year

Abstract

This study provides Class III evidence that add-on rituximab reduces gadolinium-enhancing brain lesions in multiple sclerosis.

References

YearCitations

Page 1